The relevance of its mechanism of action for pulmonary fibrosis is unclear; nintedanib has been reported to reduce SERPINH1 mRNA levels but not HSP47 protein levels in TGF-β1–treated IPF fibroblasts in vitro [75]. This evidence concerns the gene SERPINH1 and idiopathic pulmonary fibrosis.